Chief Science & Research Officer
Sarah has driven dsm-firmenich toward new frontiers of scientific excellence, building on the company’s legacy of industry-leading innovation. By embracing new technology to deliver breakthrough solutions in a fast-changing world, she harnesses an end-to-end approach to innovation — this integrates scientific discovery, intellectual property stewardship, and regulatory excellence to accelerate safe, compliant scaling across global markets.
Sarah combines an extensive background in biotechnology with a strong track record in ingredients and technology development for the consumer goods industry. Prior to joining our company in 2018, she held pivotal roles at Ginkgo Bioworks, Intrexon, and Amyris, having started her career in the field of biology and cancer therapeutics. She holds a bachelor’s degree in biology from Harvey Mudd College, as well as a master’s degree in plant biology and a Ph.D. in microbiology from the University of California, Berkeley, both in the USA.